Provocative and practice-changing research in the field of gynecologic cancers will be presented at The Annual Meeting on Women's Cancer®
A California medical research team successfully demonstrates that operating a cervical cancer screening program at an inner-city parish provides first-time care for many community residents.
Medical researchers from the University of California-Irvine have determined that women who have survived breast cancer have an elevated risk for ovarian cancer. Their findings will be presented at the 30th Annual Meeting of the Society of Gynecologic Oncologists.
Three researchers from the National Cancer Institute recently conducted a study to examine how changes in surgery and chemotherapy have affected survival for women with ovarian cancer. Their conclusions suggest that optimal multimodality therapy can improve survival for ovarian cancer patients.
Researchers from three cooperative groups joined together to determine whether supplementing radiation therapy with chemotherapy would improve the survival rate of cervical cancer victims at high risk for recurrence. Their findings will be presented at the 30th Annual Meeting of the Society of Gynecologic Oncologists.
Mutated BRCA1/2 genes have been identified as a cause of hereditary ovarian cancers. Fifteen researchers at one the nation's leading cancer institutes have identified specific qualities found in these carcinomas.
Results of First Clinical Trials for Topical Creams for HIV-Positive Women, Pap smear accuracy, and conization efficacy for HIV-Positive females are all examined at the 30th annual gathering of the Society of Gynecologic Oncologists.
Five day gathering of the 30th Annual Meeting of the Society of Gynecologic Oncologists to be held at the Hyatt Regency at Embarcadero Center in San Francisco. This document includes links to a complete listing of abstracts. There are 7 embargeod news items also contiguous to this document.
The 30th Annual meeting of the Society of Gynecologic Oncologists, March 20-24, 1999 in San Francisco, offers new findings regarding links between ovarian and breast cancer, BRCA 1/2 mutations, inner-city cervical cancer screening programs, and depression in women with gynecologic cancer.
Due to the psychosexual consequences and significant morbidity associated with the standard radical vulvectomy procedure, there has been a trend toward vulvar conservation in the management of women with vulvar cancer.
Should a post-menopausal woman, over the age of 50, who has been diagnosed with cystic ovarian tumors, be alarmed? According to conclusions reached in a new study, "The Malignant Potential of Small Cystic Ovarian Tumors in Women Over 50 Years of Age," published in the April issue of Gynecologic Oncology, alarm is unwarranted, but concern is appropriate.
Menopausal women who combine estrogen with progestin decrease their risk of developppping endometrial cancer. This is the the conclusion reached by researchers conducting a 22-year retrospective study of women 45 years of age and older.
Tulane University and University of Rochester medical researchers find that a vaccine therapy for ovarian cancer using genetically altered tumor cells could improve the effectiveness of certain chemotherapy treatments. The research will be presented at the 29th Annual Meeting of the Society of Gynecologic Oncologists.
Medical researchers from the University of California-Irvine and the State University Hospital at Stony Brook, NY, have determined that a vaginal delivery will result in an increased postpartum regression rate for pregnant women with abnormal antepartum cervical cytology. Their findings will be presented at the 29th Annual Meeting of the Society of Gynecologic Oncologists.
A revolutionary new tool has been introduced which will help women determine their risk of being attacked by one of the most deadly of all killers: reproductive cancer (cancer of the ovaries, uterus, and cervix). The Women's Cancer Network (WCN) website, at www.wcn.org, is the world's first interactive reproductive cancer website and allows a woman to instantly receive an assessment of her risk for developing these cancers.
Approximately 80% of women with cervical cancer receive a favorable prognosis if treated with a radical hysterectomy and early radiotherapy. However, in the last 30 years, the 20% mortality rate of patients following surgery has not improved. Now, medical researchers specializing in the treatment of women's cancers have completed research that offers hope to women recovering from treatment for this deadly disease. Their findings will be presented at the 29th Annual Meeting of the Society of Gynecologic Oncologists.
Medical researchers from the University of Pennsylvania Cancer Center and the Memorial Sloan-Kettering Cancer Center have conducted the first long-term follow-up of ovarian cancer patients having a negative second-look laparotomy, after treatment with platinum-based chemotherapy. Their findings will be presented at the 29th Annual Meeting of the Society of Gynecologic Oncologists.
Findings regarding vaccine therapy for ovarian cancer, platinum-based chemotherapy, the effect of route of delivery in the post-partum period and pelvic radiation therapy for cervical cancer take center stage at the 29th Annual Meeting of the Society of Gynecologic Oncologists.
Newly Released Study Recommends Genetic Testing of Gynecologic Cancer Victims in this High Risk Group, Regardless of Family History
The Society of Gynecologic Oncologists (SGO) is a non-profit, international organization of obstetricians-gynecologists who specialize in treating women with cancers of the ovary, uterus, cervix, vagina, vulva and fallopian tubes. These women's healthcare specialists have extensive training in providing gynecologic cancer care to women, including surgery, chemotherapy, immunotherapy and other innovative approaches that enhance patient care.
Gynecologic Oncology, Journal for the Society of Gynecologic Oncologists, Reports Findings That Additional Test Has Limited Clinical Benefits
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right